Skip to main content
Erschienen in: Obesity Surgery 9/2015

01.09.2015 | Original Contributions

The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis

verfasst von: Douglas Cheung, Noah J. Switzer, David Ehmann, Christopher Rudnisky, Xinzhe Shi, Shahzeer Karmali

Erschienen in: Obesity Surgery | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Significant reductions in glucose control immediately post bariatric surgery in patients with longstanding poor glycemic control can lead to the paradoxical progression of diabetic retinopathy (DR) in susceptible individuals. Bariatric surgery results in dramatic and immediate diabetic control postoperatively. We aimed to systematically review the literature to assess the effect of bariatric surgery on DR.

Methods

A comprehensive search of electronic databases (e.g., MEDLINE, EMBASE, SCOPUS, Web of Science, and the Cochrane Library) was completed. All randomized controlled trials, non-randomized comparison study, and case series were included. Inclusion criteria included English-speaking studies, enrolling ≥5 patients, and contained ophthalmological data on outcome of DR pre- and post bariatric surgery. Two independently reviewers screened abstracts, reviewed full text versions of all studies classified, and extracted data. All comparison studies included in the meta-analysis were assessed independently by two reviewers for methodological quality using the Cochrane Risk of Bias (RoB) tools. Disagreements were resolved by re-extraction, or third-party adjudication. Where possible and appropriate, a meta-analysis was conducted.

Results

A total of 277 studies were identified using our search criteria for screening. Four primary studies (n = 148 patients) met our inclusion criteria and were included in the systematic review. These included no randomized controlled trials and four non-randomized case series.
Patients with no preoperative DR (n = 80), following bariatric surgery, an average of 92.5 ± 7.4 % remained disease free, while 7.5± 7.4 % of patients progressed to DR.
Patients with diabetic retinopathy preoperatively (n = 68), following bariatric surgery, an average of 57.4 ± 18.5 % of patients had no change, 23.5 ± 18.7 % of patients had progression, and 19.2 ± 12.9 % of patients had improvement in their disease.

Conclusions

Progression of diabetic retinopathy is a significant issue postoperatively following bariatric surgery. Patients with a diagnosis of DR prior to surgery are at increased risk of further progression in their disease and should receive adequate counseling and evaluation prior to undergoing a surgical procedure. However, the few primary studies in this systematic review limit any conclusion. Further studies are needed to further evaluate these results.
Literatur
2.
Zurück zum Zitat Ghoorah K, et al. Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care. 2014: p. [Epub ahead of print]. Ghoorah K, et al. Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care. 2014: p. [Epub ahead of print].
3.
Zurück zum Zitat Petrovic MA et al. Correlation between metabolic controls and changes in retina in patients having diabetes. Med Pregl. 2014;67(1–2):49–54.PubMedCrossRef Petrovic MA et al. Correlation between metabolic controls and changes in retina in patients having diabetes. Med Pregl. 2014;67(1–2):49–54.PubMedCrossRef
4.
Zurück zum Zitat Gray SP, Jandeleit-Dahm K. The pathobiology of diabetic vascular complications–cardiovascular and kidney disease. J Mol Med (Berl). 2014;92(5):441–52.CrossRef Gray SP, Jandeleit-Dahm K. The pathobiology of diabetic vascular complications–cardiovascular and kidney disease. J Mol Med (Berl). 2014;92(5):441–52.CrossRef
5.
Zurück zum Zitat Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedCentralPubMedCrossRef Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Lannoo M, Dillemans B. Laparoscopy for primary and secondary bariatric procedures. Best Pract Res Clin Gastroenterol. 2014;28(1):159–73.PubMedCrossRef Lannoo M, Dillemans B. Laparoscopy for primary and secondary bariatric procedures. Best Pract Res Clin Gastroenterol. 2014;28(1):159–73.PubMedCrossRef
7.
Zurück zum Zitat Aminian A et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.PubMedCrossRef Aminian A et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10(4):576–82.PubMedCrossRef
8.
Zurück zum Zitat Brethauer SA et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 636–7.PubMedCentralPubMed Brethauer SA et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 636–7.PubMedCentralPubMed
9.
Zurück zum Zitat Heneghan HM et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.PubMedCrossRef Heneghan HM et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.PubMedCrossRef
10.
Zurück zum Zitat Johnson BL et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56. discussion 556–8.PubMedCrossRef Johnson BL et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56. discussion 556–8.PubMedCrossRef
11.
Zurück zum Zitat Leong WB, Taheri S. The role of bariatric surgery in the treatment of type 2 diabetes mellitus. J R Coll Physicians Edinb. 2012;42(3):194–8.PubMedCrossRef Leong WB, Taheri S. The role of bariatric surgery in the treatment of type 2 diabetes mellitus. J R Coll Physicians Edinb. 2012;42(3):194–8.PubMedCrossRef
12.
Zurück zum Zitat Silva RA, Morton JM, Moshfeghi DM. Severe worsening of diabetic retinopathy following bariatric surgery. Ophthalmic Surg Laser Imag Retina. 2013;44 Online(6): p. E11-4. Silva RA, Morton JM, Moshfeghi DM. Severe worsening of diabetic retinopathy following bariatric surgery. Ophthalmic Surg Laser Imag Retina. 2013;44 Online(6): p. E11-4.
13.
Zurück zum Zitat Mohite AAF, Shah S, Miras PR, et al. The effects of obesity surgery on diabetic retinopathy. Appetite. 2012;58(3):1171. Mohite AAF, Shah S, Miras PR, et al. The effects of obesity surgery on diabetic retinopathy. Appetite. 2012;58(3):1171.
14.
Zurück zum Zitat Zhang X, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4(27): p. [Epub ahead of print]. Zhang X, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4(27): p. [Epub ahead of print].
15.
Zurück zum Zitat Miras AD et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.PubMedCentralPubMedCrossRef Miras AD et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Thomas RL et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications. 2014;28(2):191–5.PubMedCrossRef Thomas RL et al. Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications. 2014;28(2):191–5.PubMedCrossRef
17.
Zurück zum Zitat Varadhan L et al. Bariatric surgery and diabetic retinopathy: a pilot analysis. Obes Surg. 2012;22(3):515–6.PubMedCrossRef Varadhan L et al. Bariatric surgery and diabetic retinopathy: a pilot analysis. Obes Surg. 2012;22(3):515–6.PubMedCrossRef
18.
Zurück zum Zitat Leong WBTS. The progression of diabetic retinopathy post bariatric surgery. Diabetes. 2013;2013(62):A159. Leong WBTS. The progression of diabetic retinopathy post bariatric surgery. Diabetes. 2013;2013(62):A159.
19.
Zurück zum Zitat Ros Ruiz S. Diabetic nephropathy: changes after diabetes surgery? Nutr Hosp. 2013;28 Suppl 2:57–65.PubMed Ros Ruiz S. Diabetic nephropathy: changes after diabetes surgery? Nutr Hosp. 2013;28 Suppl 2:57–65.PubMed
20.
Zurück zum Zitat Hellgren KJ, Agardh E, Bengtsson B. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study. Diabetes. 2014;63(9):3104–11.PubMedCrossRef Hellgren KJ, Agardh E, Bengtsson B. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study. Diabetes. 2014;63(9):3104–11.PubMedCrossRef
21.
Zurück zum Zitat Fante RJ, Gardner TW, Sundstrom JM. Current and future management of diabetic retinopathy: a personalized evidence-based approach. Diab Manag (Lond). 2013;3(6):481–94. Fante RJ, Gardner TW, Sundstrom JM. Current and future management of diabetic retinopathy: a personalized evidence-based approach. Diab Manag (Lond). 2013;3(6):481–94.
22.
Zurück zum Zitat Salehi M, D’Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15(3):171–9.PubMedCentralPubMedCrossRef Salehi M, D’Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15(3):171–9.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Varadhan L et al. GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract. 2011;94(3):e68–71.PubMedCrossRef Varadhan L et al. GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract. 2011;94(3):e68–71.PubMedCrossRef
24.
Zurück zum Zitat Varadhan L et al. The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res Clin Pract. 2014;103(3):e37–9.PubMedCrossRef Varadhan L et al. The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res Clin Pract. 2014;103(3):e37–9.PubMedCrossRef
25.
Zurück zum Zitat Dahl-Jorgensen K et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985;290(6471):811–5.CrossRef Dahl-Jorgensen K et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985;290(6471):811–5.CrossRef
26.
Zurück zum Zitat Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856):1306–9.PubMedCrossRef Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856):1306–9.PubMedCrossRef
27.
Zurück zum Zitat Lauritzen T et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983;1(8318):200–4.PubMedCrossRef Lauritzen T et al. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983;1(8318):200–4.PubMedCrossRef
28.
Zurück zum Zitat Parving HH et al. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism. 1983;32(9):943–9.PubMedCrossRef Parving HH et al. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism. 1983;32(9):943–9.PubMedCrossRef
29.
Zurück zum Zitat Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52(3):818–23.PubMedCrossRef Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52(3):818–23.PubMedCrossRef
30.
Zurück zum Zitat Stefanidis D et al. Revisional bariatric surgery: perioperative morbidity is determined by type of procedure. Surg Endosc. 2013;27(12):4504–10.PubMedCrossRef Stefanidis D et al. Revisional bariatric surgery: perioperative morbidity is determined by type of procedure. Surg Endosc. 2013;27(12):4504–10.PubMedCrossRef
Metadaten
Titel
The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis
verfasst von
Douglas Cheung
Noah J. Switzer
David Ehmann
Christopher Rudnisky
Xinzhe Shi
Shahzeer Karmali
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2015
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1539-9

Weitere Artikel der Ausgabe 9/2015

Obesity Surgery 9/2015 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.